Literature DB >> 25696586

A patient with four artificial heart valves after ergotamine therapy.

M Bijl, T W Galema, L A van Herwerden, M J M Kofflard, P N W M Breuls, R B A van de Brink.   

Abstract

A 67-year-old female was evaluated in the out-patient clinic because of shortness of breath on exertion and regular spells of fever. She had been taking ergotamine tartrate to treat migraine for more than 30 years. The patient had undergone aortic-valve replacement for aortic insufficiency three years before. On echocardiographic evaluation, severe retraction and insufficiency of the remaining native heart valves was demonstrated. Endocarditis and carcinoid syndrome were excluded. The mitral, tricuspid and pulmonary valves were all replaced by a mechanical valvular prosthesis. Pathological-anatomical evaluation of the three replaced valves and the aortic valve replaced three years earlier disclosed identical findings, compatible with long-term ergotamine use. Nine months after surgery, a sick sinus syndrome developed necessitating implantation of a DDDR pacemaker with a right atrial and a coronary sinus lead. Functional class according to the New York Heart Association improved from class III to I. After stopping the ergotamine, the fever disappeared. However, the migraine spells reoccurred which are now being treated with paracetamol.

Entities:  

Keywords:  aortic; ergotamine tartrate; mitral; pulmonary; tricuspid; valves

Year:  2006        PMID: 25696586      PMCID: PMC2557341     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  7 in total

1.  Valvular heart disease associated with fenfluramine-phentermine.

Authors:  H M Connolly; J L Crary; M D McGoon; D D Hensrud; B S Edwards; W D Edwards; H V Schaff
Journal:  N Engl J Med       Date:  1997-08-28       Impact factor: 91.245

2.  Tricuspid inflow and regurgitant flow dynamics after mitral valve replacement: differences relating to surgical repair of the tricuspid valve.

Authors:  N Fukuda; T Oki; A Iuchi; T Tabata; H Yamada; S Ito; N Takeichi; H Shinohara; T Socki; H Shinomiya; Y Yui; Y Tamura
Journal:  J Heart Valve Dis       Date:  1997-03

Review 3.  Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.

Authors:  M Hendrikx; J Van Dorpe; W Flameng; W Daenen
Journal:  J Heart Valve Dis       Date:  1996-03

4.  Valvular heart disease in patients taking pergolide.

Authors:  Allison M Pritchett; John F Morrison; William D Edwards; Hartzell V Schaff; Heidi M Connolly; Raul E Espinosa
Journal:  Mayo Clin Proc       Date:  2002-12       Impact factor: 7.616

5.  Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

Authors:  R B Rothman; M H Baumann; J E Savage; L Rauser; A McBride; S J Hufeisen; B L Roth
Journal:  Circulation       Date:  2000-12-05       Impact factor: 29.690

6.  Cardiovascular, respiratory, and body temperature responses of sheep to the ergopeptides ergotamine and ergovaline.

Authors:  Lance M McLeay; Barry L Smith; Gordon W Reynolds
Journal:  Am J Vet Res       Date:  2002-03       Impact factor: 1.156

7.  Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair.

Authors:  T Colombo; C Russo; G R Ciliberto; M Lanfranconi; G Bruschi; S Agati; E Vitali
Journal:  Cardiovasc Surg       Date:  2001-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.